Clinical Trial Update: A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 study evaluating combination or sequential therapy with PEGASYS (peginterferon alfa-2a) and entecavir in HBeAg-positive chronic hepatitis B; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2016-02-22